Embecta Corp., a global medical supplies company with a 100-year legacy in insulin delivery, reported its second quarter fiscal 2026 financial results on May 5, 2026. The company also declared a quarterly cash dividend of $0.01 per share. Embecta continues to focus on expanding its medical supplies business and improving lives through innovative solutions. Investors can access the detailed earnings release and listen to the company's conference call for more insights.
Neumora Therapeutics announced that its Phase 3 KOASTAL-2 and -3 trials for navacaprant, a treatment for major depressive disorder, did not meet primary or key secondary endpoints, leading to discontinuation of navacaprant's development. Despite this...
SpyGlass Pharma has named Shannon Treviño as its new general counsel. Treviño brings extensive legal and leadership experience, having previously guided Inari Medical through a $4.9 billion acquisition. Her appointment comes as SpyGlass advances its ...
Ouster's stock surged nearly 8% in premarket trading after expanding its manufacturing partnership with Benchmark Electronics to scale production of its new REV8 digital lidar sensors. The REV8 sensors target industrial, robotics, automotive, and sma...
Safehold Inc. announced a common stock dividend of $0.177 per share for the second quarter of 2026, representing an annualized rate of $0.708 per share. The dividend will be paid on July 15, 2026, to shareholders of record as of June 30, 2026. Safeho...
Wedbush analyst Dan Ives praised SpaceX's IPO as a 'Goldilocks outcome' that reassures investors and supports the tech sector. The successful debut, with shares closing 19.3% above the IPO price, signals strong investor interest and paves the way for...
